RB1 and cancer: Moreover, an integrative epigenetic analysis of RB from the same study demonstrated that multiple cancer pathways are deregulated by epigenetic mechanisms, suggesting that epigenetic dysregulation might act as a critical driver of RB tumorigenesis in the absence of other major genetic lesions apart from RB1 mutations (Zhang et al., 2012).